BioSpace News Archive

Zynerba Pharmaceuticals , Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today reported financial results for the fourth quarter and full year ended December 31, 2020, and provided an overview of recent operational highlights and a pipeline update.

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, AIM’s Chief Executive Officer, has been invited to present at the Inaugural Emerging Growth Virtual Conference , presented by M Vest LLC and Maxim Group LLC. The conference will take place March 17-19, from 9:00 am to 5:00 pm ET,

AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, announced today that James

Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the Company’s fourth quarter 2020 financial results will be released on Tuesday, March 16, 2021.

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the year ended December 31, 2020 and provided an update on recent corporate developments.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the Company has doubled its planned production volumes of its recombinant spider silk for the month of March.

Surge in the high R&D activities from the manufacturers and collaboration for new advanced surgical treatment to foster the demand

The elder care products comprise a range of products which are required for efficient elder care. Some of them are adult diapers, specific medicine, wheel chair, and back support.

Minimally invasive surgeries, which involve the use of endoscopes to view and intervene body organs through natural body orifice or small incisions, have witnessed tremendous advancement and adoption in the recent years.

Multiple displacement amplification is a commonly used technique for amplification of DNA that can amplify DNA from a sample having a trace amount of DNA.